POLINA GULKAROV: Open Payments
NPI 1326762840 · FRESH MEADOWS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 18 payments from 9 companies in 2025. Trend: 2023 $833 · 2024 $791 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 2 | $64 |
| UCB, Inc. | 2 | $57 |
| ABBVIE INC. | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35 |
| Incyte Corporation | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $23 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $21 |
Products named: Zoryve, COSENTYX, Bimzelx, SKYRIZI, DUPIXENT, OPZELURA, TREMFYA, Leqselvi.
Industry payments across NY — which companies pay providers there.
